BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Jan 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-01-03

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-31	Common Stock	A	156	$13.226	Acquired	36611	Direct
2012-01-03	Common Stock	M	2500	$11.05	Acquired	39111	Direct
2012-01-03	Common Stock	S	2500	$34.7532	Disposed	36611	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Stock Option (right to buy)	$11.05	M	2500	Disposed	2019-03-01	Common Stock (2500)	Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the isuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011.

F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on April 1, 2011.

F3: The range of sales prices received was $34.47 to $35.18. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

F4: Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.